Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (Details)

v3.20.1
STOCKHOLDERS' EQUITY (Details)
 3 Months Ended
Mar. 31, 2020
item
D
$ / shares
shares
Dec. 31, 2019
$ / shares
shares
STOCKHOLDERS' EQUITY    
Preferred Stock, Shares Authorized 5,000,000 5,000,000
Preferred Stock, Par or Stated Value Per Share | $ / shares $ 0.0001 $ 0.0001
Preferred Stock, Shares Issued 0 0
Preferred Stock, Shares Outstanding 0 0
Common Stock, Shares Authorized 200,000,000 200,000,000
Common Stock, Par or Stated Value Per Share | $ / shares $ 0.0001 $ 0.0001
Number of votes for each share | item 1  
Common Stock, Shares, Issued 5,263,695 5,285,054
Common Stock, Shares, Outstanding 5,263,695 5,285,054
Shares Subject To Possible Redemption Settlement Terms Number Of Shares 17,016,305 16,994,946
Period warrants become exercisable | D 30  
Number of days from closing of Business Combination exercise of warrants must be effective | D 90  
Warrant exercisable period 5 years  
Warrants expiration period 5 years  
Exercise price of warrants (in dollars per share) | $ / shares $ 0.01  
Number of days prior notice for redemption of warrants 30 days  
Threshold share price of common stock for warrant redemption (in dollars per share) | $ / shares $ 18.00  
Number of trading days within 30-trading day period | D 20